117 HR 6282 IH: COVID–19 Vaccine Accountability Act U.S. House of Representatives 2021-12-14 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

I117th CONGRESS1st SessionH. R. 6282IN THE HOUSE OF REPRESENTATIVESDecember 14, 2021Mr. Perry (for himself and Mr. Gohmert) introduced the following bill; which was referred to the Committee on Energy and CommerceA BILLTo amend title III of the Public Health Service Act to eliminate immunity for manufacturers of COVID–19 vaccines, and for other purposes.

1.

Short title

This Act may be cited as the COVID–19 Vaccine Accountability Act.

2.

Liability of COVID–19 vaccine manufacturers

(a)

Covered countermeasure

Section 319F–3(i)(1) of the Public Health Service Act (42 U.S.C. 247d–6d(i)(1)) is amended by adding at the end the following: Such term does not include vaccines for COVID–19 that are required (directly or as a condition of employment, schooling, or otherwise) under Federal, State, or local law to be administered to individuals eligible to receive such a vaccine..(b)

Covered person

Section 319F–3(i)(2) of the Public Health Service Act (42 U.S.C. 247d–6d(i)(2)) is amended by adding at the end the following:Such term does not include a manufacturer of a vaccine described in the matter following subparagraph (D) of paragraph (1)..(c)

Limitation of liability

Section 319F–3 of the Public Health Service Act (42 U.S.C. 247d–6d) is amended by adding at the end the following: (j)

Limitation on liability

Pursuant to, and consistent with, the sovereign immunity reservation specified in subsection (f), the liability of the United States for a death or injury caused by the administration of a vaccine for COVID–19 occurring on or after January 1, 2020 shall not exceed $10,000. .